J. B. Groce

Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.

Geno J. Merli, J. B. Groce · PubMed · 2010 · 110 citations · Full text

Pharmacotherapy, Thrombosis, Hematology +19

Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program.

J. B. Groce · PubMed · 1999 · 40 citations

Acute Dvt, Pharmacotherapy, Hospital Medicine +21

Applying Scientific Criteria to Therapeutic Interchange: A Balanced Analysis of Low-Molecular-Weight Heparins

Geno J. Merli, Gordon J. Vanscoy, Thomas L. Rihn et al. · Journal of Thrombosis and Thrombolysis · 2001 · 33 citations

Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels

Jacqueline Saw, Dean J. Kereiakes, Kenneth W. Mahaffey et al. · Thrombosis Research · 2003 · 15 citations

Pharmacology, Medicine, Clinical Chemistry +1

Heparin dosage adjustment in patients with deep-vein thrombosis using heparin concentrations rather than activated partial thromboplastin time.

J. B. Groce, Pim Gal, Jean B. Douglas et al. · PubMed · 1987 · 13 citations

Pharmacotherapy, Heparin Dosage Adjustment, Thrombosis +16